Amy | Sales manager
Phone:+86 19142414382(whatsapp)
Email:shengzhikai3@shengzhikai.com
Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province
| Product Name | Liraglutide |
| CAS | 204656-20-2 |
| MF | C172H265N43O51 |
| NW | 3751.202 |
Appearance | White Powder |
| Storage | Cool Dry Place |
Shelf Life | 2 years |
Grade | Pharmaceutical Grade |
The Liraglutide is a transparent, colorless solution. The dosage form is subcutaneous injection. After more than 10 years of research and development, the Liraglutide has many functions, such as promoting islet cell regeneration, lowering blood sugar, reducing weight and protecting the cardiovascular system, saxe nda is a drug used to treat chronic obesity as a supplement to diet and exercise. The Liraglutide is an acylated human Glucagon-like peptide-1(Glp-1) receptor agonist. It has 97% amino acid sequence homology with human endogenous GLP-1(7-37) and retains all the biological activity of GLP-1, it has the action of GLP-1 receptor. Through the expression of recombinant DNA in Saccharomyces cerevisiae, its molecular structure is only one amino acid different from that of Natural Glp-1, the structure of Glp-1 is modified in two parts: the 34th lysine is replaced by arginine, and a glutamic acid-mediated side chain of 16-carbon palmitoyl fatty acid is added to the 26th lysine.
China
